Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
237,4 CHF | -2,51 % | -0,47 % | -8,62 % |
24/05 | El índice del mercado suizo cae porque los datos económicos provocan de nuevo el nerviosismo por los tipos de interés | MT |
24/05 | ROCHE HOLDINGS AG : Deutsche Bank se mantiene neutral. | ZD |
Resumen de negocios
Ventas por actividad
CHF en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceuticals
76,6
%
| 48 628 | 73,2 % | 46 279 | 76,6 % | -4,83 % |
Diagnostics
23,4
%
| 17 798 | 26,8 % | 14 162 | 23,4 % | -20,43 % |
Ventas por región
CHF en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
46,9
%
| 29 313 | 44,1 % | 28 352 | 46,9 % | -3,28 % |
Rest of Europe
16,1
%
| 10 328 | 15,5 % | 9 703 | 16,1 % | -6,05 % |
Rest of Asia
14,7
%
| 9 852 | 14,8 % | 8 890 | 14,7 % | -9,76 % |
Japan
7,4
%
| 6 452 | 9,7 % | 4 464 | 7,4 % | -30,81 % |
Latin America
4,9
%
| 2 870 | 4,3 % | 2 971 | 4,9 % | +3,52 % |
Germany
4,8
%
| 3 318 | 5,0 % | 2 893 | 4,8 % | -12,81 % |
Africa, Australia and Oceania
2,0
%
| 1 520 | 2,3 % | 1 212 | 2,0 % | -20,26 % |
Switzerland
1,8
%
| 1 671 | 2,5 % | 1 118 | 1,8 % | -33,09 % |
Rest of North America
1,4
%
| 1 102 | 1,7 % | 838 | 1,4 % | -23,96 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 49 | 01/01/03 | |
Severin Schwan
CHM | Chairman | 57 | 01/01/08 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01/04/11 |
Pascale Schmidt
CMP | Compliance Officer | 51 | 01/01/20 |
Levi Garraway
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bruno Eschli
IRC | Investor Relations Contact | - | - |
Silke Hörnstein
PRN | Corporate Officer/Principal | 49 | 01/01/15 |
Annette Luther
SEC | Corporate Secretary | 54 | 01/04/20 |
General Counsel | 60 | 01/04/20 | |
Human Resources Officer | 57 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03/03/15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01/01/96 | |
Patrick Frost
BRD | Director/Board Member | 56 | 17/03/20 |
Hans Clevers
PRN | Corporate Officer/Principal | 67 | 05/03/19 |
Severin Schwan
CHM | Chairman | 57 | 01/01/08 |
Anita Hauser
BRD | Director/Board Member | 55 | 14/03/17 |
Director/Board Member | 58 | 01/03/16 | |
Jemilah Mahmood
BRD | Director/Board Member | - | - |
Akiko Iwasaki
BRD | Director/Board Member | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 106 691 000 | 28 989 189 ( 27,17 %) | 0 | 88,91 % |
Acción B | 1 | 702 562 700 | 690 549 674 ( 98,29 %) | 12 011 755 ( 1,710 %) |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
1 005 670 000 | 59.89% | 32 272 955 970 $ | |
ROCHE HOLDING AG 1.43% | 10 073 029 | 1.43% | 2 422 842 800 $ |
2 744 120 | 8.15% | 33 917 323 $ | |
454 961 | 3.02% | 9 636 074 $ | |
ALIGOS THERAPEUTICS, INC. 15.19% | 11 025 941 | 15.19% | 9 019 220 $ |
1 893 | 0.06% | 1 486 $ |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Viewics India Pvt Ltd.
| |
Roche Finance Europe BV
|
Finance/Rental/Leasing
|
Roche Financial Management Ltd.
| |
Roche Catalyst Investments Ltd.
| |
Roche Financial Investments Ltd.
| |
Roche Intertrade Ltd.
| |
Roche Pharmholding BV
Roche Pharmholding BV Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The company is based in Woerden, Netherlands. |
Medical Distributors
|
Roche Diagnostics India Pvt Ltd.
Roche Diagnostics India Pvt Ltd. Medical SpecialtiesHealth Technology Founded in 1988, Roche Diagnostics India Pvt Ltd. is a subsidiary of Roche Holding AG. The company is based in Mumbai, India. The Indian company manufactures diagnostic systems and devices for patients, clinicians, and researchers. |
Medical Specialties
|
Roche Diagnostics Belgium NV
Roche Diagnostics Belgium NV BiotechnologyHealth Technology Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker. |
Biotechnology
|
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+38,51 % | 727 mil M | |
+33,05 % | 599 mil M | |
-6,23 % | 354 mil M | |
+18,78 % | 328 mil M | |
+1,35 % | 277 mil M | |
+16,00 % | 243 mil M | |
+8,09 % | 205 mil M | |
+6,19 % | 164 mil M | |
+0,31 % | 164 mil M |
- Bolsa de valores
- Acciones
- Acción ROG
- Acción RO
- Empresa Roche Holding AG